- Home
- Symposium
- Special Report
- Research reviews
- CPD
- Editorial
- Casebook
- Photoguide
- Haslam
Other sections
Special Interest
PRACTITIONER 2009;253(1719):7
Weigh up the risks and benefits of IAD in prostate cancer
01 Jun 2009
This article can be accessed only if you are a paid-up subscriber to The Practitioner.

= Registered users